Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,691 annual reports · 4,011 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 477 of 641 · 7,691 filings

  • Fractyl Health (GUTS) FY2024 10-K risk factors
    107 risks

    Fractyl Health faces high concentration risk on its lead product Revita and Rejuva gene therapy candidates, ongoing cash burn with net losses, and strict regulatory and clinical hurdles.

    Filed Mar 03, 2025
  • Hilton Grand Vacations (HGV) FY2024 10-K risk factors
    68 risks

    Timeshare operations depend heavily on consumer discretionary spending, macroeconomic conditions, and the Hilton brand license.

    Filed Mar 03, 2025
  • Hut 8 (HUT) FY2024 10-K risk factors
    62 risks

    Hut 8's risk section is dominated by Bitcoin price volatility, power cost and availability, and operational dependencies on mining infrastructure.

    Filed Mar 03, 2025
  • ImmunityBio (IBRX) FY2024 10-K risk factors
    80 risks

    ImmunityBio relies heavily on commercializing its approved product ANKTIVA while managing significant debt and revenue interest obligations to Oberland and Dr. Soon-Shiong. The company faces manufacturing buildout risks, reliance on key personnel Dr. Soon-Shiong, and external supply shortages like TICE BCG.

    Filed Mar 03, 2025
  • indie Semiconductor (INDI) FY2024 10-K risk factors
    64 risks

    Indie Semiconductor faces high automotive market concentration, substantial reliance on Asian contract manufacturing, and complex regulatory exposure in China.

    Filed Mar 03, 2025
  • Indivior Pharmaceuticals (INDV) FY2024 10-K risk factors
    64 risks

    Indivior faces heavy litigation, reliance on third-party manufacturers, and regulatory scrutiny over controlled substances like buprenorphine. The business is exposed to pricing pressures, potential Medicaid cuts, and international tariff proposals on pharmaceuticals.

    Filed Mar 03, 2025
  • Innovex International (INVX) FY2024 10-K risk factors
    71 risks

    Innovex faces severe cyclicality in oilfield services, dependent on volatile oil and gas prices. The recent merger with Dril-Quip creates significant integration risks. Global operations expose the company to geopolitical, supply chain, and trade compliance risks.

    Filed Mar 03, 2025
  • Kayne Anderson BDC (KBDC) FY2024 10-K risk factors
    65 risks

    Kayne Anderson BDC faces core risks from its limited operating history since 2021 and 2024 IPO, heavy reliance on leverage via credit facilities and senior notes, and interest rate volatility impacting portfolio company loan payments.

    Filed Mar 03, 2025
  • Kinetik Holdings (KNTK) FY2024 10-K risk factors
    32 risks

    Kinetik Holdings relies heavily on its Delaware and Permian Basin midstream assets, customer drilling activity, and joint venture performance.

    Filed Mar 03, 2025
  • Lightbridge (LTBR) FY2024 10-K risk factors
    31 risks

    Lightbridge relies heavily on US government funding and faces significant capital needs with $40.0 million in cash against a $164.2 million accumulated deficit. Commercializing its nuclear fuel depends heavily on test reactors, national laboratory resources, and overcoming unproven commercial reactor performance. The company faces supply chain vulnerabilities for HALEU and other materials, alongside potential dilution from proposed share increases.

    Filed Mar 03, 2025
  • MARA Holdings (MARA) FY2024 10-K risk factors
    53 risks

    MARA's risks are dominated by Bitcoin price volatility and the operational demands of its HODL and hashrate expansion strategies. Energy constraints, regulatory uncertainty, and cybersecurity threats to digital asset holdings form secondary core risks.

    Filed Mar 03, 2025
  • Mercantile Bank (MBWM) FY2024 10-K risk factors
    116 risks

    The risk profile for Mercantile Bank Corporation centers around credit quality in commercial lending, interest rate fluctuations affecting net interest income, and liquidity management for unfunded commitments.

    Filed Mar 03, 2025

Companies covered

4,011 companies

371 more under A